Unlocking the Future of the Comprehensive Metabolic Panel (CMP) Testing Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the comprehensive metabolic panel (cmp) testing market size evolved in recent years?
In recent times, there has been a robust growth in the market size of the comprehensive metabolic panel (CMP) testing. An upsurge from $17.04 billion in 2024 to $18.39 billion in 2025 is expected, demonstrating a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period is attributed to several factors such as an increase in chronic diseases, a demand for comprehensive health evaluations, a focus on preventive care by healthcare systems, a rise in conditions related to lifestyle, and a patient-focused approach to healthcare.
What are the predictions for the comprehensive metabolic panel (cmp) testing market size in the coming years?
The market size for comprehensive metabolic panel (CMP) testing is anticipated to exhibit substantial growth over the upcoming years, with predictions indicating it will reach $26.02 billion by 2029, with a compound annual growth rate (CAGR) of 9.1%. The expected growth within this forecast period can be traced back to various factors such as the rise of personalized and precision healthcare, the incorporation of CMP testing into telehealth services, increasing demand for thorough health screenings, growing wellness and preventive health movements, as well as changes in healthcare policies and regulations. In the same forecast period, tendencies towards ongoing and longitudinal monitoring, telemedicine-friendly report formats, normalization of reference ranges, application of wearable health technology and a focus on patient education and engagement are expected to define the market trends.
Get your comprehensive metabolic panel (cmp) testing market report here!
What key factors are fueling the growth of the comprehensive metabolic panel (cmp) testing market?
The surge in cardiovascular diseases and diabetes cases is anticipated to stimulate the comprehensive metabolic panel (CMP) testing market’s expansion. Cardiovascular disorders, connected to atherosclerosis or fatty deposits’ accretion inside arteries, impact the heart or blood vessels. Moreover, high blood glucose levels lead to diabetes. Comprehensive metabolic panel (CMP) blood tests can identify glucose levels. Therefore, as the incidences of diabetes and cardiovascular diseases increase, the requirement for their detection via blood tests such as the CMP blood test will bolster the market’s progress. As an illustration, the Australian Institute of Health and Welfare, a national organization based in Australia managing public health and wellness, reported that in December 2023, the doctor-verified deaths caused by CHD were 13,700 in 2020, elevated to 14,100 in 2021 and 14,900 in 2022. In addition, as per the International Diabetes Federation, a diabetes federation located in Belgium, in June 2022, the global prevalence of diabetes had risen to 10.5%, with still over half (44.7%) of the people undiagnosed. Hence, the upswing in cardiovascular diseases and diabetes prevalence is fuelling the comprehensive metabolic panel (CMP) testing market’s growth.
How is the global comprehensive metabolic panel (cmp) testing market divided into key segments?
The comprehensive metabolic panel (CMP) testing market covered in this report is segmented –
1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) By End User: Laboratories, Point Of Care (PoC)
Subsegments:
1) By Kidney Disease: Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), Glomerulonephritis
2) By Liver Disease: Hepatitis (Viral And Non-Viral), Cirrhosis, Fatty Liver Disease
3) By Diabetes: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
4) By Other Diseases: Cardiovascular Diseases, Electrolyte Imbalances, Metabolic Disorders, Pancreatic Diseases
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12362&type=smp
Who are the key firms paving the way for growth in the comprehensive metabolic panel (cmp) testing market?
Major companies operating in the comprehensive metabolic panel (CMP) testing market include Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC
Which trends are expected to transform the comprehensive metabolic panel (cmp) testing market?
The emergence of technological innovations is a notable trend gaining traction in the comprehensive metabolic panel (CMP) testing market. Prominent firms within the CMP testing market are creating innovative technologies to maintain their market standing. For instance, HealthifyMe, a wellness and fitness service company based in India, introduced their flagship fitness plan, HealthifyPro, in April 2022. The metabolic panel of the HealthifyPro program is rooted in a blood test capable of assessing 80 or more different parameters. Key aspects of HealthifyPro encompass a biosensor system (BIOS), a smart scale, health coaching, HealthifyMe’s AI assistant, and a metabolic panel. This system merges user’s glucose pattern information with their food intake and other workout habits to generate a unique approach tailored to each user.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12362
What regions are contributing significantly to the growth of the comprehensive metabolic panel (cmp) testing market?
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (CMP) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Blood Collection Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
Blood Culture Tests Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report
Blood Processing Devices And Consumables Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
